0001062993-19-002835.txt : 20190710
0001062993-19-002835.hdr.sgml : 20190710
20190710101516
ACCESSION NUMBER: 0001062993-19-002835
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190701
FILED AS OF DATE: 20190710
DATE AS OF CHANGE: 20190710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wegman Mark N
CENTRAL INDEX KEY: 0001405235
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 19948298
MAIL ADDRESS:
STREET 1: 43 OVERLOOK ROAD
CITY: OSSINING
STATE: NY
ZIP: 10562
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4/A
1
form4a.xml
AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4/A
2019-07-01
2019-07-02
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001405235
Wegman Mark N
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
1
0
0
0
Common Stock, $0.001 par value
2019-07-01
4
A
0
1890
0
A
67162
D
Grant of restricted stock units under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan.
The purpose of this Form 4/A is solely to correct the amount of securities beneficially owned by the reporting person due to a prior administrative error and does not represent any acquisition or disposition of shares by the reporting person.
/s/ Mark N. Wegman, by Carl A. Valenstein, attorney-in-fact
2019-07-10